-China stops P3 Remdesivir (Rvir) trial because they couldn’t complete enrollment due to weak efficacy
-NEJM reports only 68% of Rvir patients show improvement after 18days 

24hrs before Opex expiration we get “leak” that Rvir is miracle drug that cures 90% in a week
$gild $spx